# Phase I Comparative Bioavailability Study

> **NCT00777582** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **AstraZeneca** · enrollment: 197 (actual)

## Conditions studied

- Solid Tumors

## Interventions

- **DRUG:** AZD2281

## Key facts

- **NCT ID:** NCT00777582
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2008-10-27
- **Primary completion:** 2009-02-06
- **Final completion:** 2027-03-31
- **Target enrollment:** 197 (ACTUAL)
- **Last updated:** 2026-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00777582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00777582, "Phase I Comparative Bioavailability Study". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00777582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*